Enzymatic synthesis of psilocybin
Fricke, J., Blei, F., & Hoffmeister, D. | Angewandte Chemie International Edition | 25 August 2017
A Systematic Review Of Research On N,N-Dimethyltryptamine
Hristova, D., & Zhelyazkova-Savova, M. | Scripta Scientifica Vox Studentium | 1 August 2017
Harmine is an inflammatory inhibitor through the suppression of NF-κB signaling
Liu, X., Li, M., Tan, S., Wang, C., Fan, S., & Huang, C. | Biochemical and Biophysical Research Communications | 29 July 2017
Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species
Hatipoglu, S. D., Yalcinkaya, B., Akgoz, M., Ozturk, T., Goren, A. C., & Topcu, G. | Phytochemical Analysis | 19 July 2017
Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species
Hatipoglu, S. D., Yalcinkaya, B., Akgoz, M., Ozturk, T., Goren, A. C., & Topcu, G. | Phytochemical Analysis | 19 July 2017
Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats
Simón-Arceo, K., González-Trujano, M. E., Coffeen, U., Fernández-Mas, R., Mercado, F., Almanza, A., ... & Pellicer, F. | Journal of Ethnopharmacology | 12 July 2017
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
Lewis, C. R., Preller, K. H., Kraehenmann, R., Michels, L., Stämpfli, P., & Vollenweider, F. X. | NeuroImage | 12 July 2017
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. | Current Topics in Behavioral Neuroscience | 5 July 2017
The Effects of Hallucinogens on Gene Expression
Martin, D. A., & Nichols, C. D. | Current Topics in Behavioral Neurosciences | 5 July 2017
LSD experiments by the United States Army
Ross, C. A. | History of Psychiatry | 1 July 2017
A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects
Dolder, P. C., Grünblatt, E., Müller, F., Borgwardt, S. J., & Liechti, M. E. | Frontiers in Pharmacology | 28 June 2017
In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against Influenza virus
Moradi, M. T., Karimi, A., Rafieian-Kopaei, M., & Fotouhi, F. | Microbial Pathogenesis | 16 June 2017
Effect of psilocybin on empathy and moral decision-making
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. | International Journal of Neuropsychopharmacology | 16 June 2017
Neuroticism is associated with challenging experiences with psilocybin mushrooms
Barrett, F. S., Johnson, M. W., & Griffiths, R. R. | Personality and Individual Differences | 7 June 2017
Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice
Correa-Netto, N. F., Coelho, L. S., Galfano, G. S., Nishide, F., Tamura, F., Shimizu, M. K., ... & Linardi, A. | Brazilian Journal of Medical and Biological Research | 5 June 2017
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
Dolder, P. C., Müller, F., Schmid, Y., Borgwardt, S. J., & Liechti, M. E. | Psychopharmacology | 27 May 2017
Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial
Dolder, P. C., Liechti, M. E., & Rentsch, K. M. | Journal of Clinical Laboratory Analysis | 26 May 2017
Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability
Sherwood, A. M., Crowley, R. S., Paton, K. F., Biggerstaff, A., Neuenswander, B., Day, V. W., ... & Prisinzano, T. E. | Journal of Medicinal Chemistry | 11 May 2017
A Longitudinal Study of Self-Reported Psychopathology in Beginning Ecstasy and Amphetamine Users: A Third Follow-Up Evaluation
Wagner, D., Sauder, T., Koester, P., Gouzoulis-Mayfrank, E., & Daumann, J. | Substance Use & Misuse | 4 May 2017
Growing Evidence for Heterogeneous Synaptic Localization of 5-HT2A Receptors
Bécamel, C., Berthoux, C., Barre, A., & Marin, P. | ACS Chemical Neuroscience | 1 May 2017
Changes in Resting-State Global Brain Connectivity in LSD-Induced Altered States of Consciousness are Attributable to the 5-HT2A Receptor
Preller, K., Schleifer, C., Stämpfli, P., Krystal, J., Vollenweider, F., & Anticevic, A. | Biological Psychiatry | 29 April 2017
MDMA does not alter responses to the Trier Social Stress Test in humans
Bershad, A. K., Miller, M. A., & de Wit, H. | Psychopharmacology | 21 April 2017
Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
Mueller, F., Lenz, C., Dolder, P. C., Harder, S., Schmid, Y., Lang, U. E., ... & Borgwardt, S. | Translational Psychiatry | 4 April 2017
Psychotria viridis: Chemical constituents from leaves and biological properties
SOARES, D., DUARTE, L. P., CAVALCANTI, A. D., SILVA, F. C., BRAGA, A. D., LOPES, M. T., ... & VIEIRA-FILHO, S. A. | Anais da Academia Brasileira de Ciências | 1 April 2017
Psychedelics As A New Anti-Inflammatory Therapeutic For Atherosclerosis
Nichols, C. D., Sebastian, M., & Flanagan, T. | The FASEB Journal | 1 April 2017